<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="27230" end="27241" sStart="-1" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="In Experiment 3, the behavior of nuclei of confluent or nocodazole-treated cells &lt;b&gt;transferred&lt;/b&gt; into enucleated M I or M II oocytes was examined after activation." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="5784" end="5795" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="When nocodazole-treated cells were &lt;b&gt;transferred&lt;/b&gt; into M I oocytes, one spot of condensed chromatin and one polar body (Figure 1C) was observed in 13." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="2263" end="2275" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="However, there is only one report in which cloned animals have been produced from embryos reconstructed by &lt;b&gt;transferring&lt;/b&gt; differentiated cells into preactivated recipient oocytes [ 8] and the ability of preactivated recipient oocytes to reprogram differentiated cells is now in debate." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="28248" end="28260" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="Experiment 4 was undertaken to compare in vitro developmental abilities of reconstructed embryos produced by &lt;b&gt;transferring&lt;/b&gt; confluent or nocodazole-treated cells into enucleated M I or M II oocytes as described above." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="16964" end="16975" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="The blastocyst formation rate in our study is similar to results from the recent reports in which porcine adult somatic (cumulus) cells (5-10%) [ 29, 51] or fetal fibroblasts (1-16%) [ 11, 29, 51, 52, 53, 54, 55, 56, 57] were &lt;b&gt;transferred&lt;/b&gt; into enucleated M II oocytes matured in media supplemented with pFF." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="5784" end="5795" sStart="null" offset="0" sid="null" wn="2 3" wnkey="null" text="When nocodazole-treated cells were &lt;b&gt;transferred&lt;/b&gt; into M I oocytes, one spot of condensed chromatin and one polar body (Figure 1C) was observed in 13." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="13430" end="13441" sStart="null" offset="0" sid="null" wn="2 3" wnkey="null" text="Therefore, it is possible that reprogramming of nuclei &lt;b&gt;transferred&lt;/b&gt; into M I oocytes is inhibited by cytochalasin B. Thirdly, M I and M II oocytes may differ in cytoplasmic competence." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="976" end="987" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="Recently, it has been shown that when mouse embryonic stem cells [ 13] and bovine somatic cells [ 14] in the M phase were &lt;b&gt;transferred&lt;/b&gt; into non-treated recipients, the chromosome constitution of reconstructed embryos was normal in that the second polar body was excluded after parthenogenetic activation and the embryos developed to offspring." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="16548" end="16560" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="In the present study, 7.6% of reconstructed embryos produced by &lt;b&gt;transferring&lt;/b&gt; confluent adult somatic cells into enucleated M II oocytes matured in the protein-free medium developed to the blastocyst stage." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="23348" end="23359" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="Cell-oocyte complexes were washed in TCM-199 supplemented with 10% FCS, &lt;b&gt;transferred&lt;/b&gt; to the same medium and kept under 5% CO 2 in air at 38." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="7208" end="7220" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="7%) of embryos produced by &lt;b&gt;transferring&lt;/b&gt; confluent or nocodazole-treated cells into M I oocytes (Table 3)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="10432" end="10444" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="The blastocyst formation rate of reconstructed embryos produced by &lt;b&gt;transferring&lt;/b&gt; confluent cells into M I oocytes was significantly lower than that of embryos reconstituted with confluent cells and M II oocytes although there were no significant differences in percentages of embryos with swollen nuclei between different maturation stages of recipient oocytes." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="2503" end="2514" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="When bovine somatic cells were &lt;b&gt;transferred&lt;/b&gt; into preactivated recipient oocytes, the resulting reconstructed embryo development was limited, since all embryos arrested at the 8-cell stage regardless of the cell cycle of the donor cells [ 14]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="9845" end="9857" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="Moreover, some reconstructed embryos produced by &lt;b&gt;transferring&lt;/b&gt; confluent cells developed to the blastocyst stage." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="6599" end="6611" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="9% of embryos produced by &lt;b&gt;transferring&lt;/b&gt; confluent cells into M I or M II oocytes with no significant differences." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="22088" end="22099" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="Cumulus cells were removed by vortexing with 0.1% (w:v) hyaluronidase and denuded oocytes were &lt;b&gt;transferred&lt;/b&gt; into 100 ?l of Hepes-buffered TCM-199 supplemented with 7.5 ?g/ml cytochalasin B (Sigma) and 10% FCS with the osmolarity adjusted to 300 mOsm by adding sorbitol (manipulation medium) at 29 or 42 h after IVM." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="2976" end="2987" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="In contrast, when nuclei in G0 or G1 phase are &lt;b&gt;transferred&lt;/b&gt; into non-treated recipients, reconstructed embryos can develop to offspring in many species [ 1, 2, 3, 4, 5, 6, 8, 9, 10, 11]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="7733" end="7745" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="5%) blastocysts (Figure 2) were obtained and this percentage was significantly (P &lt; 0.05) lower than that of embryos produced by &lt;b&gt;transferring&lt;/b&gt; confluent cells into M II oocytes (7." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="8577" end="8588" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="When donor nuclei are &lt;b&gt;transferred&lt;/b&gt; into non-treated M II recipient oocytes that have high MPF activity, various changes referred to as nuclear remodeling occur in the introduced nuclei." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="9499" end="9510" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="In the present study, when confluent or nocodazole-treated cells were &lt;b&gt;transferred&lt;/b&gt; into enucleated M I oocytes, nuclear swelling was observed in 34." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="26485" end="26496" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="In Experiment 2, we examined the behavior before activation of donor cell nuclei &lt;b&gt;transferred&lt;/b&gt; into enucleated M I oocytes." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="14454" end="14465" sStart="null" offset="0" sid="null" wn="7" wnkey="transfer%2:35:00::" text="In contrast, no reconstructed embryos developed to the blastocyst stage regardless of the maturation stage of the recipient oocytes when nocodazole-treated cells were &lt;b&gt;transferred&lt;/b&gt;, although nuclear swelling was observed in 34." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="21161" end="21172" sStart="null" offset="0" sid="null" wn="7" wnkey="transfer%2:35:00::" text="Oocytes were &lt;b&gt;transferred&lt;/b&gt; into tubes containing Hepes-buffered TCM-199 (Gibco BRL, Grand &lt;b&gt;Island&lt;/b&gt;, NY) supplemented with 0.57 mM cysteine, 10 ng/ml epidermal growth factor (Sigma), 100 IU/ml penicillin, 100 ?g/ml streptomycin, 0.25 ng/ml amphotericin, 0.01 IU/ml porcine FSH (Sioux Biochemicals, Sioux Center, IA), 0.01 IU/ml porcine LH (Sioux Biochemicals) and 0.1% (w:v) polyvinyl alcohol (maturation medium) [ 50], and shipped to the laboratory overnight (20-24 h) at 38." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="27230" end="27241" sStart="null" offset="0" sid="null" wn="3 2" wnkey="null" text="In Experiment 3, the behavior of nuclei of confluent or nocodazole-treated cells &lt;b&gt;transferred&lt;/b&gt; into enucleated M I or M II oocytes was examined after activation." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="5784" end="5795" sStart="null" offset="0" sid="null" wn="3 2" wnkey="null" text="When nocodazole-treated cells were &lt;b&gt;transferred&lt;/b&gt; into M I oocytes, one spot of condensed chromatin and one polar body (Figure 1C) was observed in 13." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="2263" end="2275" sStart="null" offset="0" sid="null" wn="3 2" wnkey="null" text="However, there is only one report in which cloned animals have been produced from embryos reconstructed by &lt;b&gt;transferring&lt;/b&gt; differentiated cells into preactivated recipient oocytes [ 8] and the ability of preactivated recipient oocytes to reprogram differentiated cells is now in debate." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="28248" end="28260" sStart="null" offset="0" sid="null" wn="3 2" wnkey="null" text="Experiment 4 was undertaken to compare in vitro developmental abilities of reconstructed embryos produced by &lt;b&gt;transferring&lt;/b&gt; confluent or nocodazole-treated cells into enucleated M I or M II oocytes as described above." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="16964" end="16975" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="The blastocyst formation rate in our study is similar to results from the recent reports in which porcine adult somatic (cumulus) cells (5-10%) [ 29, 51] or fetal fibroblasts (1-16%) [ 11, 29, 51, 52, 53, 54, 55, 56, 57] were &lt;b&gt;transferred&lt;/b&gt; into enucleated M II oocytes matured in media supplemented with pFF." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="5784" end="5795" sStart="null" offset="0" sid="null" wn="4 3 9" wnkey="null" text="When nocodazole-treated cells were &lt;b&gt;transferred&lt;/b&gt; into M I oocytes, one spot of condensed chromatin and one polar body (Figure 1C) was observed in 13." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="13430" end="13441" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="Therefore, it is possible that reprogramming of nuclei &lt;b&gt;transferred&lt;/b&gt; into M I oocytes is inhibited by cytochalasin B. Thirdly, M I and M II oocytes may differ in cytoplasmic competence." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="12927" end="12939" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="In the present study, reconstructed embryos produced by &lt;b&gt;transferring&lt;/b&gt; confluent cells into M I oocytes were cultured in the maturation medium supplemented with cytochalasin B to prevent loss of chromosomes by polar body formation." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="27230" end="27241" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="In Experiment 3, the behavior of nuclei of confluent or nocodazole-treated cells &lt;b&gt;transferred&lt;/b&gt; into enucleated M I or M II oocytes was examined after activation." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="5784" end="5795" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="When nocodazole-treated cells were &lt;b&gt;transferred&lt;/b&gt; into M I oocytes, one spot of condensed chromatin and one polar body (Figure 1C) was observed in 13." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="28449" end="28460" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="2 medium for 3 days, the embryos were &lt;b&gt;transferred&lt;/b&gt; into 100 ?l of G2." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="2263" end="2275" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="However, there is only one report in which cloned animals have been produced from embryos reconstructed by &lt;b&gt;transferring&lt;/b&gt; differentiated cells into preactivated recipient oocytes [ 8] and the ability of preactivated recipient oocytes to reprogram differentiated cells is now in debate." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="28248" end="28260" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="Experiment 4 was undertaken to compare in vitro developmental abilities of reconstructed embryos produced by &lt;b&gt;transferring&lt;/b&gt; confluent or nocodazole-treated cells into enucleated M I or M II oocytes as described above." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="26655" end="26666" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="M I oocytes were enucleated at 29 h after IVM and confluent or nocodazole-treated cells were &lt;b&gt;transferred&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="16964" end="16975" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="The blastocyst formation rate in our study is similar to results from the recent reports in which porcine adult somatic (cumulus) cells (5-10%) [ 29, 51] or fetal fibroblasts (1-16%) [ 11, 29, 51, 52, 53, 54, 55, 56, 57] were &lt;b&gt;transferred&lt;/b&gt; into enucleated M II oocytes matured in media supplemented with pFF." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="5165" end="5176" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="When confluent cells were &lt;b&gt;transferred&lt;/b&gt; into M I oocytes, the fusion rate (60." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="5560" end="5572" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="0%) of embryos reconstructed by &lt;b&gt;transferring&lt;/b&gt; confluent cells and this percentage was significantly (P &lt; 0.05) higher than that (63." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="13430" end="13441" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="Therefore, it is possible that reprogramming of nuclei &lt;b&gt;transferred&lt;/b&gt; into M I oocytes is inhibited by cytochalasin B. Thirdly, M I and M II oocytes may differ in cytoplasmic competence." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-213X-1-12.anc" start="10780" end="10787" sStart="null" offset="14" sid="r8.suggest.v.0964" wn="3" wnkey="suggest%2:32:02::" text="These results suggest that the reprogramming of donor nuclei may be started but is not completed in some embryos reconstituted with M I oocytes." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="7022" end="7026" sStart="null" offset="0" sid="null" wn="3" wnkey="rate%1:07:00::" text="The cleavage &lt;b&gt;rate&lt;/b&gt; (38." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="7022" end="7026" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="The cleavage &lt;b&gt;rate&lt;/b&gt; (38." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-213X-1-12.anc" start="1090" end="1096" sStart="null" offset="252" sid="r9.normal.j.0207" wn="3" wnkey="normal%3:00:03::" text="Recently, it has been shown that when mouse embryonic stem cells [ 13] and bovine somatic cells [ 14] in the M phase were transferred into non-treated recipients, the chromosome constitution of reconstructed embryos was normal in that the second polar body was excluded after parthenogenetic activation and the embryos developed to offspring." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-213X-1-12.anc" start="13193" end="13199" sStart="null" offset="68" sid="r9.normal.j.0220" wn="1" wnkey="normal%3:00:01::" text="However, it has been reported recently that morphologically normal M I spindles are formed but further meiotic progression does not occur in porcine oocytes matured in a cytochalasin B-containing medium [ 38]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="17013" end="17020" sStart="null" offset="0" sid="null" wn="1" wnkey="mature%2:30:00::" text="The blastocyst formation &lt;b&gt;rate&lt;/b&gt; in our study is similar to results from the recent reports in which porcine adult somatic (cumulus) cells (5-10%) [ 29, 51] or fetal fibroblasts (1-16%) [ 11, 29, 51, 52, 53, 54, 55, 56, 57] were transferred into enucleated M II oocytes &lt;b&gt;matured&lt;/b&gt; in media supplemented with pFF." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="17013" end="17020" sStart="null" offset="0" sid="null" wn="1" wnkey="mature%2:30:00::" text="The blastocyst formation &lt;b&gt;rate&lt;/b&gt; in our study is similar to results from the recent reports in which porcine adult somatic (cumulus) cells (5-10%) [ 29, 51] or fetal fibroblasts (1-16%) [ 11, 29, 51, 52, 53, 54, 55, 56, 57] were transferred into enucleated M II oocytes &lt;b&gt;matured&lt;/b&gt; in media supplemented with pFF." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="13306" end="13313" sStart="null" offset="0" sid="null" wn="1" wnkey="mature%2:30:00::" text="However, it has been reported recently that morphologically normal M I spindles are formed but further meiotic progression does not occur in porcine oocytes &lt;b&gt;matured&lt;/b&gt; in a cytochalasin B-containing medium [ 38]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="16628" end="16635" sStart="null" offset="0" sid="null" wn="1" wnkey="mature%2:30:00::" text="In the present study, 7.6% of reconstructed embryos produced by transferring confluent adult somatic cells into enucleated M II oocytes &lt;b&gt;matured&lt;/b&gt; in the protein-free medium developed to the blastocyst stage." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="17490" end="17498" sStart="null" offset="0" sid="null" wn="1" wnkey="mature%2:30:00::" text="Although this study did not compare defined IVM medium with complex medium the results indicate that protein-free IVM medium is suitable for &lt;b&gt;maturing&lt;/b&gt; recipient oocytes for the production of cloned embryos." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="17013" end="17020" sStart="null" offset="0" sid="null" wn="1" wnkey="mature%2:30:00::" text="The blastocyst formation &lt;b&gt;rate&lt;/b&gt; in our study is similar to results from the recent reports in which porcine adult somatic (cumulus) cells (5-10%) [ 29, 51] or fetal fibroblasts (1-16%) [ 11, 29, 51, 52, 53, 54, 55, 56, 57] were transferred into enucleated M II oocytes &lt;b&gt;matured&lt;/b&gt; in media supplemented with pFF." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="13306" end="13313" sStart="null" offset="0" sid="null" wn="1" wnkey="mature%2:30:00::" text="However, it has been reported recently that morphologically normal M I spindles are formed but further meiotic progression does not occur in porcine oocytes &lt;b&gt;matured&lt;/b&gt; in a cytochalasin B-containing medium [ 38]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="16628" end="16635" sStart="null" offset="0" sid="null" wn="1" wnkey="mature%2:30:00::" text="In the present study, 7.6% of reconstructed embryos produced by transferring confluent adult somatic cells into enucleated M II oocytes &lt;b&gt;matured&lt;/b&gt; in the protein-free medium developed to the blastocyst stage." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="17490" end="17498" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="Although this study did not compare defined IVM medium with complex medium the results indicate that protein-free IVM medium is suitable for &lt;b&gt;maturing&lt;/b&gt; recipient oocytes for the production of cloned embryos." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="21256" end="21262" sStart="null" offset="0" sid="null" wn="1" wnkey="island%1:17:00::" text="Oocytes were &lt;b&gt;transferred&lt;/b&gt; into tubes containing Hepes-buffered TCM-199 (Gibco BRL, Grand &lt;b&gt;Island&lt;/b&gt;, NY) supplemented with 0.57 mM cysteine, 10 ng/ml epidermal growth factor (Sigma), 100 IU/ml penicillin, 100 ?g/ml streptomycin, 0.25 ng/ml amphotericin, 0.01 IU/ml porcine FSH (Sioux Biochemicals, Sioux Center, IA), 0.01 IU/ml porcine LH (Sioux Biochemicals) and 0.1% (w:v) polyvinyl alcohol (maturation medium) [ 50], and shipped to the laboratory overnight (20-24 h) at 38." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-213X-1-12.anc" start="21256" end="21262" sStart="null" offset="0" sid="null" wn="2147483647" wnkey="null" text="Oocytes were &lt;b&gt;transferred&lt;/b&gt; into tubes containing Hepes-buffered TCM-199 (Gibco BRL, Grand &lt;b&gt;Island&lt;/b&gt;, NY) supplemented with 0.57 mM cysteine, 10 ng/ml epidermal growth factor (Sigma), 100 IU/ml penicillin, 100 ?g/ml streptomycin, 0.25 ng/ml amphotericin, 0.01 IU/ml porcine FSH (Sioux Biochemicals, Sioux Center, IA), 0.01 IU/ml porcine LH (Sioux Biochemicals) and 0.1% (w:v) polyvinyl alcohol (maturation medium) [ 50], and shipped to the laboratory overnight (20-24 h) at 38." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-213X-1-12.anc" start="3545" end="3549" sStart="null" offset="54" sid="r10.high.j.0678" wn="1" wnkey="high%3:00:02::" text="Because many studies suggest that exposure to high activity of MPF is effective for reprogramming a donor nucleus from a differentiated cell [ 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 14], M I oocytes may reprogram somatic cell nuclei as well." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-213X-1-12.anc" start="7908" end="7917" sStart="null" offset="110" sid="r8.1.different.j.0795" wn="1" wnkey="different%3:00:00::" text="There were no significant differences in mean numbers of cells in the blastocysts between different maturation stages of the recipient oocytes." />
  </sentences>
</list>